Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Hims & Hers Health, Inc. (HIMS : NYSE)
 
 • Company Description   
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.

Number of Employees: 2,442

 
 • Price / Volume Information   
Yesterday's Closing Price: $27.71 Daily Weekly Monthly
20 Day Moving Average: 11,804,864 shares
Shares Outstanding: 233.31 (millions)
Market Capitalization: $6,465.11 (millions)
Beta: 2.42
52 Week High: $65.30
52 Week Low: $13.74
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -12.78% -12.39%
12 Week -8.15% -10.11%
Year To Date -14.66% -24.31%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2269 CHESTNUT STREET SUITE 523
-
SAN FRANCISCO,CA 94123
USA
ph: 415-851-0195
fax: -
investors@forhims.com http://www.hims.com
 
 • General Corporate Information   
Officers
Andrew Dudum - Chief Executive Officer
Oluyemi Okupe - Chief Financial Officer
Irene Becklund - Chief Accounting Officer
Delos Cosgrove - Director
Anja Manuel - Director

Peer Information
Hims & Hers Health, Inc. (HLIS)
Hims & Hers Health, Inc. (AZTA)
Hims & Hers Health, Inc. (APYI)
Hims & Hers Health, Inc. (RNVA)
Hims & Hers Health, Inc. (HMSY)
Hims & Hers Health, Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 433000106
SIC: 8011
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 11/02/26
Share - Related Items
Shares Outstanding: 233.31
Most Recent Split Date: (:1)
Beta: 2.42
Market Capitalization: $6,465.11 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.09 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.00 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 19.55% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/02/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 19.95
Price/Cash Flow: 33.11
Price / Sales: 2.51
EPS Growth
vs. Year Ago Period: -158.82%
vs. Previous Quarter: 44.44%
Sales Growth
vs. Year Ago Period: 38.25%
vs. Previous Quarter: 23.86%
ROE
06/30/26 - -6.51
03/31/26 - 6.10
12/31/25 - 22.48
ROA
06/30/26 - -1.20
03/31/26 - 1.52
12/31/25 - 7.02
Current Ratio
06/30/26 - 0.93
03/31/26 - 1.69
12/31/25 - 1.90
Quick Ratio
06/30/26 - 0.87
03/31/26 - 1.56
12/31/25 - 1.70
Operating Margin
06/30/26 - -1.19
03/31/26 - 1.37
12/31/25 - 5.35
Net Margin
06/30/26 - -5.51
03/31/26 - -0.56
12/31/25 - 5.47
Pre-Tax Margin
06/30/26 - -6.35
03/31/26 - -1.61
12/31/25 - 5.28
Book Value
06/30/26 - 1.39
03/31/26 - 1.93
12/31/25 - 2.38
Inventory Turnover
06/30/26 - 9.22
03/31/26 - 6.59
12/31/25 - 6.08
Debt-to-Equity
06/30/26 - 4.21
03/31/26 - 2.18
12/31/25 - 1.80
Debt-to-Capital
06/30/26 - 80.82
03/31/26 - 68.59
12/31/25 - 64.26
 

Powered by Zacks Investment Research ©